Navigation Links
Watson Confirms Welchol® Oral Suspension Patent Challenge
Date:1/25/2011

MORRISTOWN, N.J., Jan. 25, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Colesevelam HCI powder for oral suspension, 1.875 gm/packet and 3.75 gm/packet.  Watson's Colesevelam HCI powder for oral suspension is a generic version of Daiichi Sankyo, Inc.'s Welchol ® oral suspension, which is indicated to reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia as monotherapy or in combination with an hydroxymethyl-glutarylcoenzyme A (HMG CoA) reductase inhibitor (statin); to reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age with heterozygous familial hypercholesterolemia as monotherapy or in combination with a statin after failing an adequate trial of diet therapy; and to improve glycemic control in adults with type 2 diabetes mellitus.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)

Daiichi Sankyo and Genzyme Corporation filed suit against Watson on January 21, 2011 in the United States District Court for the District of Delaware seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent No. 5,693,675.  Daiichi Sankyo's lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA until June 19, 2013, or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.  

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialize
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... HOUSTON , Aug. 21, 2014   Memorial Hermann ... Anderson Cancer Center today announced a new partnership to ... network of community breast care centers in the greater ... November, MD Anderson will become the exclusive provider of professional ... care centers, located in Memorial City, The Woodlands ...
(Date:8/21/2014)... Ill. , Aug. 21, 2014 ... Baxter International Inc. today announced positive results from ... 855, an investigational, extended half-life recombinant factor VIII ... [Antihemophilic Factor (Recombinant)], which met its primary endpoint ... prophylaxis arm compared to the on-demand arm. ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
... LLC is pleased to announce that it has been ... Human Research Protection Programs (AAHRPP) at the September meeting ... in the Kansas City metro area, Mid*Lands is an ... welfare of research study participants. Mid*Lands IRB specializes in ...
... More than 1,700 medical device and diagnostics ... 24 countries and 33 states – attended the ... MedTech Conference this week in Washington, D.C. ... (Photo:   http://www.newscom.com/cgi-bin/prnh/20101022/DC86995-a ) ...
Cached Medicine Technology:Mid*Lands IRB, LLC - First Independent IRB in Kansas and the Kansas City Area Awarded Accreditation for Protecting Research Participants 2AdvaMed 2010 Sets New Attendance Record: More than 1,700 Device and Diagnostics Leaders from Across the Country and Around the World Came to Washington, D.C. 2
(Date:8/23/2014)... On Monday, August 18th, The ... suffered by Community Health Systems, which operates over ... million records containing Personally Identifiable Information (PII) like names, ... who was engaged to investigate the incident, the belief ... of cyber attackers based in China, who they say ...
(Date:8/23/2014)... August 23, 2014 Pixel Film Studios, a ... today the release of ProIntro Vol.3, a customizable title ... and professional tile just by dragging ProIntro Vol.3 in their ... Vol.3 is a definite time saver and i think our ... with 30 beautifully designed titles made with Final Cut Pro ...
(Date:8/23/2014)... (PRWEB) August 23, 2014 Teen drug ... Carolina. It’s no different in Wilmington, NC. Substance abuse ... are falling victim to drug and alcohol dependency in ... are looking to overcome substance abuse, but don’t know ... adolescent treatment facility can be a challenge because most ...
(Date:8/22/2014)... IT manager of Top10BestSEOHosting.com is a web professional who ... recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) is one ... is a popular supplier of cheap web hosting, and ... affordable rates. It offers three Linux shared hosting plans. ... the length of the contract. The longest contract length ...
(Date:8/22/2014)... UT (PRWEB) August 22, 2014 Today, ... a new guide on Account-Based Health Plans. , According ... (ABHPs) as a strategy to lower the cost of ... types of medical spending accounts, however, can be confusing. ... chart to learn the four main types of ABHPs. ...
Breaking Medicine News(10 mins):Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 3Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 4Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2
... 4 Clarient, Inc. (Nasdaq: CLRT ), a ... pharmaceutical industry, today announced that it has rescheduled the release ... December 31, 2008 to Wednesday, March 11th in order to ... with the filing of its Form 10-K for the year ...
... the CDC website can be a frightening experience for ... two million patients will acquire a hospital infection this ... as a result. CDC studies found that hospital infections ... additional days to a hospital stay on average, costing ...
... MOUNTAIN VIEW, Calif., March 4 Based ... and biotechnology market, Frost & Sullivan presents ... American Frost & Sullivan Award for Entrepreneurial ... the company,s success in achieving its growth ...
... quarter net service revenues increased 84% to $66.2 million; ... million- Fourth quarter Visiting Nurse (VN) segment net revenues ... revenues rose 80% to $173.0 million- Fourth quarter net ... income increased 114% to $16.3 million- Fourth quarter diluted ...
... TouchOut Cancer, the first cancer news iPhone application, features daily cancer ... The Leukemia & Lymphoma Society and I,m Too Young For This ... Bryan Clay and more. , ... Chicago, IL (PRWEB) ...
... a leader in the healthcare documentation training industry, will release a ... of March. This program was developed in collaboration with industry experts ... growing medical coding and billing industry. , ... Springville, ...
Cached Medicine News:Health News:Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day 2Health News:Mercy Hospital at Folsom Acquires Advanced Germicidal Technology to Battle MRSA, C. diff, Acinetobacter and Other Drug-Resistant Pathogens 2Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 2Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 3Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 4Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 2Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 3Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 4Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 5Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 6Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 7Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 8Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 9Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 10Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 11Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 12Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 13Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 14Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 15Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 16Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 17Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 18Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 19Health News:Almost Family Reports Fourth Quarter and Full Year 2008 Results 20Health News:MedicinePhone Launches TouchOut Cancer on Apple App Store 2Health News:MedicinePhone Launches TouchOut Cancer on Apple App Store 3Health News:Career Step Launches New Training Program for Careers in Secure Healthcare Industry 2
... An Precise placement integrated with the CRW ... offers a unique off-board cable drive mechanism ... drive without the problem of fluid leakage. ... for future upgrades and simplified removal during ...
... The OEV-203 Monitors are designed exclusively for ... use with all Olympus endoscopy systems. When ... equipment, the OEV-203 provides sharp, high-resolution images ... with the view - and details - ...
... It features over 600 TV lines of resolution ... four color temperature selections, scanning size selection and ... allows the user to easily set up and ... for brightness, chroma, phase, contrast, volume and aperture ...
... flat panel is designed for medical imaging. The 18 ... radiology and ultrasound. It can be mounted on a ... arm. It allows for RGB, s-video and composite inputs ... built in VGA input. In VGA mode, its resolution ...
Medicine Products: